Clinical Trials on ER-positive Breast Cancer in Germany
Total 556 results
-
AIO-Studien-gGmbHNo longer availablethe Treatment Hand-foot Syndrome Patients With Gastrointestinal Tumors or Breast Cancer, Who Are Treated With CapecitabineGermany
-
Cancer Trials IrelandCompletedMetastatic Breast CancerSpain, Ireland, Israel, Finland, Portugal, France, Germany, Norway
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI)CompletedBreast Cancer | Contralateral Breast CancerUnited States, Germany, Canada
-
West German Study GroupAgendiaRecruitingFemale Breast CancerGermany
-
University Hospital TuebingenUnknownMetastatic Breast CancerGermany
-
MedSIRCompletedMetastatic Breast CancerSpain, Czechia, France, Germany, Italy, Russian Federation, United Kingdom
-
Hoffmann-La RocheRoche Pharma AGCompletedMetastatic Breast CancerItaly, Spain, Canada, United States, Belgium, France, Germany
-
BayerCompletedBreast Neoplasms | Breast Cancer, MetastaticGermany, Italy, Israel, Poland, Switzerland, United Kingdom, Greece
-
BayerCompletedMetastatic Breast CancerSpain, Austria, United Kingdom, France, Finland, Poland, Germany, Sweden, Italy, Switzerland
-
Novartis PharmaceuticalsCompletedBreast Cancer | Prostate Cancer | Bone MetastasisGermany
-
European Organisation for Research and Treatment...Pfizer; ETOP IBCSG Partners Foundation; UNICANCER; Breast International Group; SOLTI... and other collaboratorsActive, not recruitingBreast Cancer Stage II | Breast Cancer Stage IIISpain, France, Italy, Belgium, Jordan, Poland, Germany, United Kingdom, Portugal
-
MedSIRHoffmann-La RocheActive, not recruitingEarly Breast CancerSpain, Italy, Germany, Bulgaria, Hungary
-
Merrimack PharmaceuticalsCompletedHer2 Negative Breast Cancer PatientsUnited States, Spain, Canada, Germany, Russian Federation
-
Breast International GroupJules Bordet Institute; Frontier Science & Technology Research Foundation,...RecruitingMetastatic Breast CancerBelgium, Spain, Portugal, United Kingdom, Italy, Germany, Iceland, Luxembourg, Sweden, Switzerland
-
AstraZenecaCompleted
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Krebsforschung Schweiz, Bern, Switzerland; Rising Tide FoundationRecruitingLymphedema, Breast CancerSpain, Switzerland, United States, Germany, Argentina, Austria, Belgium, Brazil, Canada, Greece, Italy, Netherlands, Romania, Sweden
-
Hoffmann-La RocheCompletedBreast CancerAustralia, Spain, United Kingdom, Germany, Belgium, Italy, Finland, Netherlands
-
Fondazione MichelangeloHoffmann-La RocheActive, not recruitingInvasive Breast CancerSpain, Italy, Germany, Austria
-
University Hospital TuebingenRobert Bosch Gesellschaft für Medizinische Forschung mbHCompletedBreast Cancer | Hand-Foot SyndromeGermany
-
Technical University of MunichCompletedBreast Cancer | Gastric CancerGermany
-
Technical University of MunichCompletedHereditary Breast and Ovarian CancerGermany
-
Cantargia ABActive, not recruitingColorectal Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Pancreatic Ductal AdenocarcinomaAustria, Denmark, Germany, Belgium, Spain, Latvia, Netherlands, Lithuania, Estonia, Sweden, Norway
-
Hologic, Inc.CompletedBreast Cancer FemaleNetherlands, France, Germany, Italy, Spain, United Kingdom
-
Hoffmann-La RocheCompletedTriple-negative Breast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Belgium, Brazil, Germany, Taiwan, Australia, Japan, Spain, Poland, Italy
-
Eli Lilly and CompanyCompletedBreast CancerNetherlands, Spain, Italy, France, Germany
-
AIO-Studien-gGmbHAstraZenecaRecruitingNSCLC | EGFR Positive Non-small Cell Lung Cancer | OligoprogressionGermany
-
Cephalon, Inc.CompletedBreast CancerAustria, Belgium, France, Germany, Italy, Spain
-
Novartis PharmaceuticalsCompleted
-
AmgenRoche-GenentechCompletedMetastatic Colorectal Cancer | Metastatic Triple Negative Breast CancerUnited States, Belgium, Spain, Australia, Switzerland, Germany
-
University Hospital TuebingenUnknownMetastatic Breast CancerGermany
-
German Breast GroupGilead Sciences; ETOP IBCSG Partners Foundation; UNICANCER; Austrian Breast & Colorectal... and other collaboratorsActive, not recruitingTriple Negative Breast Cancer | HER2-negative Breast CancerFrance, Spain, Germany, Switzerland, Austria, Ireland, Belgium
-
AstraZenecaDaiichi Sankyo, Inc.CompletedBreast CancerUnited States, Germany, Italy, Korea, Republic of, United Kingdom, Portugal, Australia, Japan, Canada, France
-
European Organisation for Research and Treatment...TerminatedBreast CancerFrance, Belgium, Slovenia, Israel, United Kingdom, Germany, Austria
-
West German Study GroupEli Lilly and Company; Genomic Health®, Inc.RecruitingBreast Cancer FemaleGermany
-
Bristol-Myers SquibbCompletedCancer | Breast CancerBelgium, United States, Spain, France, Germany, Australia, Canada, Puerto Rico
-
SOLTI Breast Cancer Research GroupEisai Inc.CompletedBreast CancerSpain, France, Portugal, Germany
-
Eli Lilly and CompanyCompletedBreast CancerItaly, Spain, Turkey, Germany, South Africa
-
Center for Epidemiology and Health Research, GermanyBayerCompletedBreast Cancer | Venous Thromboembolism | Arterial ThromboembolismGermany
-
West German Study GroupNovartis; Genomic Health®, Inc.Recruiting
-
Genentech, Inc.Hoffmann-La RocheCompletedBreast CancerUnited States, Belgium, France, Germany, United Kingdom, Spain
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
San Antonio Military Medical CenterNuGenerex Immuno-Oncology; Norwell, Inc.CompletedBreast CancerUnited States, Germany, Greece
-
Institut de Recherches Internationales ServierBreast International GroupCompletedBreast CancerUnited Kingdom, Italy, France, Belgium, Australia, Canada, Germany, Hungary, Spain
-
Eli Lilly and CompanyCompletedBreast CancerArgentina, Belgium, Germany, Romania, Spain, United Kingdom
-
German Breast GroupAstraZenecaCompletedBreast Cancer | Triple Negative Breast Neoplasms | HRpos Breast Neoplasms | BRCA 1 /2 and / or HRDGermany
-
Elevation OncologyTerminatedMetastatic Breast CancerGermany, Spain, United States, Austria, Belgium, Canada
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerGermany
-
Hoffmann-La RocheCompletedEarly Breast CancerSpain, Korea, Republic of, Australia, Taiwan, Ukraine, Poland, Russian Federation, United States, Germany, Brazil, Hungary
-
European Organisation for Research and Treatment...Active, not recruitingBreast CancerItaly, Spain, Poland, Belgium, Jordan, United Kingdom, Netherlands, France, Germany, Switzerland
-
SanofiCompletedBreast CancerUnited States, France, Canada, Germany, Italy, Netherlands, Spain, Switzerland, Turkey, Belgium, Argentina, Denmark, Colombia, Korea, Republic of, South Africa